What is BCHT's health score?

Birchtech Corp. (BCHT) has a TradeApes health score of 35 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BCHT's estimated fair value?

Based on our 5-year discounted cash flow model, Birchtech Corp.'s estimated fair value is $3.03 per share, representing a 58.1% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is BCHT undervalued or overvalued?

Our model currently rates BCHT as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BCHT... Refresh in a moment for the full analysis.

Birchtech Corp. (BCHT)

Healthcare Undervalued low weak

$1.92

Updated: 2026-06-06

TradeApes Score

Financial Strength

0 Stressed

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

55 Mixed

Risk

70 Healthy

Est. Fair Value $3.03

DCF Upside +58.1%

Sector Rank #2384 of 6651

Key Findings

+ Low stock compensation — SBC below 3% of revenue

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.